Trial NCT05712941

View at ClinicalTrials.gov 
Org. Study IDs: EQ132-303
Secondary IDs: ENGOT-EN17 GOG-3075

Last trial update was posted on 2023-11-03

MeSH Interventions

Letrozole

MeSH Conditions

Carcinoma Endometrial Neoplasms

Other Conditions

Endometrial Carcinoma

Stopping Reasons

The study is being closed based on corporate changes at EQRx and is not related to any efficacy or safety issues with lerociclib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID